Transforming sanofi-aventis into a healthcare leader

 
In February, we announced our vision to become a diversified global healthcare leader.
To achieve this goal, we are transforming sanofi-aventis to ensure sustainable, profitable growth. The core objectives in this process:
 

• Increasing innovation in our R&D
  By focusing on patients’ needs, we intend to become the most productive R&D organization in the healthcare sector. To do this, we are carrying out a complete review of our portfolio. Moving forward, we will evolve our decision-making process, creating an innovative and dynamic organization, developing a clear strategy to tap into the best science around the world.

• Adapting our company to future challenges
  The crucial questions facing our industry are clear: “How can we change the model? How can we create more sustainable growth?” To answer these questions, we have to identify the resources and the competencies we need to grow. We are growing in markets as diverse as the patients themselves. New technologies open new avenues of research. Vaccines, biologicals, branded generics and consumer healthcare (OTC) require our teams to move out of the classical pharmaceutical mindset. Our company has a history of adapting to opportunity and we will build upon this strength.

• Pursuing external growth opportunities
  Why must we diversify? Classical small molecules pharmaceuticals, our core business activity, are vulnerable to patent expiry. So we want to build businesses like vaccines, like consumer health care, like branded generics, to create a basis for more sustainable growth. We will of course maintain our pharmaceutical business, but we will also reply to future global healthcare challenges with a broader platform of offerings, which are more affordable and accessible to patients with fewer economic resources.

I’ll be keeping you informed about how we are achieving these goals. Check our website regularly, or sign up for the RSS feeds, to find out more.

Chris Viehbacher, CEO